NCT03886493 Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer Status TERMINATED Phase PHASE2
NCT03838731 Study in Cat-Allergic Patients With Asthma to Evaluate the Efficacy of a Single Dose of REGN1908-1909 to Reduce Bronchoconstriction Upon Cat Allergen Challenge Status COMPLETED Phase PHASE2
NCT03793608 Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy Status COMPLETED Phase PHASE2
NCT03787095 Safety and Immunotherapeutic Activity of an Anti-PD-1 Antibody (Cemiplimab) in Participants With HIV-1 on Suppressive cART Status TERMINATED Phase PHASE1/PHASE2
NCT03782532 Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma Status COMPLETED Phase PHASE3
NCT03767738 Study to Evaluate an Aflibercept (EYLEA®) Prefilled Syringe Status COMPLETED Phase PHASE4
NCT03761108 Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma Status RECRUITING Phase PHASE1/PHASE2
NCT03746704 Study of ImmunoPet Imaging of PD-L1 in Tumors Using 89Zr-DFO-REGN3504 in Adult Participants With Advanced PD-L1 Positive Malignancies Status TERMINATED Phase PHASE1
NCT03738423 Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis Status TERMINATED Phase PHASE2
NCT03736967 Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis Status TERMINATED Phase PHASE2
NCT03712904 Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma Status TERMINATED Phase PHASE2
NCT03710941 Safety and Efficacy of REGN2477+REGN1033 in Patients With Sporadic Inclusion Body Myositis Status WITHDRAWN Phase PHASE2
NCT03694158 Investigating Dupilumab's Effect in Asthma by Genotype Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT03691974 Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients With Pain Due to Osteoarthritis of the Hip or Knee Status COMPLETED Phase PHASE2
NCT03690869 REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma Status TERMINATED Phase PHASE1/PHASE2
NCT03682770 Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy) Status COMPLETED Phase PHASE2
NCT03679845 Study to Assess Sarilumab in Halting Progression of Morphea Status WITHDRAWN Phase PHASE1/PHASE2